BusinessRedHill Biopharma Announces Availability of Its Annual Report on Form 20-F Through Its WebsiteBy Nasdaq OMXFeb 23, 2017, 3:07 PM UTC
BusinessFibrocell Announces Dosing of First Patient in Phase I/II Clinical Trial of FCX-007 Gene Therapy for Treatment of Recessive Dystrophic Epidermolysis BullosaBy Nasdaq OMXFeb 23, 2017, 1:01 PM UTC
BusinessFibrocell Announces Dosing of First Patient in Phase I/II Clinical Trial of FCX-007 Gene Therapy for Treatment of Recessive Dystrophic Epidermolysis BullosaBy Nasdaq OMXFeb 23, 2017, 1:01 PM UTC
BusinessCyclacel Announces Top-Line Results From Pivotal Phase 3 SEAMLESS Study in Elderly Patients With Acute Myeloid LeukemiaBy Nasdaq OMXFeb 23, 2017, 11:57 AM UTC
BusinessBio-Optronics® and OmniComm Systems® to Provide Top-Tier Cancer Research Institution With CTMS and EDC for Real-Time Data AccessBy Nasdaq OMXFeb 22, 2017, 1:01 PM UTC
BusinessStudy Published in PAIN Reveals Nicotinamide Riboside is an Effective Tool in Relieving Chemotherapy-Induced Peripheral Neuropathy Induced by a Common Anticancer AgentBy Nasdaq OMXFeb 22, 2017, 11:30 AM UTC
BusinessNewLink Genetics to Host Its Fourth Quarter and Year End 2016 Financial Results Conference Call on February 28, 2017By Nasdaq OMXFeb 20, 2017, 12:00 PM UTC
